374 related articles for article (PubMed ID: 11850822)
21. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
Ellinger J; Haan K; Heukamp LC; Kahl P; Büttner R; Müller SC; von Ruecker A; Bastian PJ
Prostate; 2008 Jan; 68(1):42-9. PubMed ID: 18004747
[TBL] [Abstract][Full Text] [Related]
22. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance.
Reibenwein J; Pils D; Horak P; Tomicek B; Goldner G; Worel N; Elandt K; Krainer M
Prostate; 2007 Mar; 67(4):427-32. PubMed ID: 17192910
[TBL] [Abstract][Full Text] [Related]
23. The use of real-time quantitative polymerase chain reaction to detect hypermethylation of the CpG islands in the promoter region flanking the GSTP1 gene to diagnose prostate carcinoma.
Chu DC; Chuang CK; Fu JB; Huang HS; Tseng CP; Sun CF
J Urol; 2002 Apr; 167(4):1854-8. PubMed ID: 11912447
[TBL] [Abstract][Full Text] [Related]
24. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
[TBL] [Abstract][Full Text] [Related]
25. DNA methyltransferase levels and altered CpG methylation in the total genome and in the GSTP1 gene in human glioma cells transfected with sense and antisense DNA methyltransferase cDNA.
Antoun G; Baylin SB; Ali-Osman F
J Cell Biochem; 2000 Apr; 77(3):372-81. PubMed ID: 10760946
[TBL] [Abstract][Full Text] [Related]
26. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells.
Lin X; Tascilar M; Lee WH; Vles WJ; Lee BH; Veeraswamy R; Asgari K; Freije D; van Rees B; Gage WR; Bova GS; Isaacs WB; Brooks JD; DeWeese TL; De Marzo AM; Nelson WG
Am J Pathol; 2001 Nov; 159(5):1815-26. PubMed ID: 11696442
[TBL] [Abstract][Full Text] [Related]
27. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
28. DNA methylation and gene silencing in cancer: which is the guilty party?
Clark SJ; Melki J
Oncogene; 2002 Aug; 21(35):5380-7. PubMed ID: 12154400
[TBL] [Abstract][Full Text] [Related]
29. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells.
Jarrard DF; Kinoshita H; Shi Y; Sandefur C; Hoff D; Meisner LF; Chang C; Herman JG; Isaacs WB; Nassif N
Cancer Res; 1998 Dec; 58(23):5310-4. PubMed ID: 9850055
[TBL] [Abstract][Full Text] [Related]
30. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia.
Melki JR; Vincent PC; Clark SJ
Cancer Res; 1999 Aug; 59(15):3730-40. PubMed ID: 10446989
[TBL] [Abstract][Full Text] [Related]
31. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
[TBL] [Abstract][Full Text] [Related]
32. Methylation of the CD44 metastasis suppressor gene in human prostate cancer.
Lou W; Krill D; Dhir R; Becich MJ; Dong JT; Frierson HF; Isaacs WB; Isaacs JT; Gao AC
Cancer Res; 1999 May; 59(10):2329-31. PubMed ID: 10344738
[TBL] [Abstract][Full Text] [Related]
33. Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas.
Kim J; Lee HS; Bae SI; Lee YM; Kim WH
Anticancer Res; 2005; 25(6B):4013-9. PubMed ID: 16309193
[TBL] [Abstract][Full Text] [Related]
34. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker.
Lee WH; Isaacs WB; Bova GS; Nelson WG
Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):443-50. PubMed ID: 9184779
[TBL] [Abstract][Full Text] [Related]
35. Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer.
Suh CI; Shanafelt T; May DJ; Shroyer KR; Bobak JB; Crawford ED; Miller GJ; Markham N; Glode LM
Mol Cell Probes; 2000 Aug; 14(4):211-7. PubMed ID: 10970725
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy.
Bastian PJ; Ellinger J; Heukamp LC; Kahl P; Müller SC; von Rücker A
Eur Urol; 2007 Mar; 51(3):665-74; discussion 674. PubMed ID: 16956712
[TBL] [Abstract][Full Text] [Related]
37. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
[TBL] [Abstract][Full Text] [Related]
38. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
Kang GH; Lee S; Lee HJ; Hwang KS
J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
[TBL] [Abstract][Full Text] [Related]
39. Hypermethylation of the CpG islands in the promoter region flanking GSTP1 gene is a potential plasma DNA biomarker for detecting prostate carcinoma.
Chuang CK; Chu DC; Tzou RD; Liou SI; Chia JH; Sun CF
Cancer Detect Prev; 2007; 31(1):59-63. PubMed ID: 17291695
[TBL] [Abstract][Full Text] [Related]
40. Gene promoter methylation in prostate tumor-associated stromal cells.
Hanson JA; Gillespie JW; Grover A; Tangrea MA; Chuaqui RF; Emmert-Buck MR; Tangrea JA; Libutti SK; Linehan WM; Woodson KG
J Natl Cancer Inst; 2006 Feb; 98(4):255-61. PubMed ID: 16478744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
